Nuon Therapeutics, Inc.

Quick facts

Phase 2 pipeline

• Combination 400
• Combination 600
  Combination 600 is a combination of two or more drugs that work together to treat a specific condition.
• Combination - Tranilast and Allopurinol · Rheumatology, Allergy
  Tranilast inhibits the activity of mast cells and platelets, while Allopurinol inhibits xanthine oxidase.
• Combination - Tranilast and Febuxostat · Oncology, Cardiovascular
  Tranilast is a selective inhibitor of PDGF receptors, while Febuxostat is a xanthine oxidase inhibitor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Nuon Therapeutics, Inc. portfolio CI brief
• Nuon Therapeutics, Inc. pipeline updates RSS